Alimera Sciences Inc (ALIM)
3.68
-0.03
(-0.81%)
USD |
NASDAQ |
May 01, 14:30
Alimera Sciences Cash from Investing (Quarterly): -0.085M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.085M |
| September 30, 2023 | -0.004M |
| June 30, 2023 | -75.43M |
| March 31, 2023 | -0.009M |
| December 31, 2022 | -0.084M |
| September 30, 2022 | -0.13M |
| June 30, 2022 | 0.108M |
| March 31, 2022 | -0.149M |
| December 31, 2021 | -0.121M |
| September 30, 2021 | -0.31M |
| June 30, 2021 | -0.106M |
| March 31, 2021 | -0.084M |
| December 31, 2020 | -0.085M |
| September 30, 2020 | -0.318M |
| June 30, 2020 | -0.192M |
| March 31, 2020 | -0.025M |
| December 31, 2019 | -0.024M |
| September 30, 2019 | -0.111M |
| June 30, 2019 | -0.024M |
| March 31, 2019 | -0.015M |
| December 31, 2018 | -0.001M |
| September 30, 2018 | -0.051M |
| June 30, 2018 | -0.032M |
| March 31, 2018 | -0.091M |
| December 31, 2017 | -0.004M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.067M |
| June 30, 2017 | -0.11M |
| March 31, 2017 | -0.057M |
| December 31, 2016 | -0.064M |
| September 30, 2016 | -0.006M |
| June 30, 2016 | -0.041M |
| March 31, 2016 | -0.075M |
| December 31, 2015 | -0.081M |
| September 30, 2015 | -0.033M |
| June 30, 2015 | -0.177M |
| March 31, 2015 | -0.16M |
| December 31, 2014 | -25.68M |
| September 30, 2014 | 0.047M |
| June 30, 2014 | -0.198M |
| March 31, 2014 | -0.012M |
| December 31, 2013 | -0.587M |
| September 30, 2013 | -0.005M |
| June 30, 2013 | -0.353M |
| March 31, 2013 | -0.028M |
| December 31, 2012 | -0.008M |
| September 30, 2012 | -0.004M |
| June 30, 2012 | -0.011M |
| March 31, 2012 | 0.50M |
| December 31, 2011 | -0.004M |
| September 30, 2011 | -0.024M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-75.43M
Minimum
Jun 2023
0.108M
Maximum
Jun 2022
-4.062M
Average
-0.085M
Median
Dec 2020
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly and Co | -2.924B |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 9.462M |
| iBio Inc | 0.00 |
| Theriva Biologics Inc | -0.056M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 3.77M |
| Cash from Financing (Quarterly) | -0.078M |
| Free Cash Flow | -89.79M |
| Free Cash Flow Per Share (Quarterly) | 0.0704 |
| Free Cash Flow to Equity (Quarterly) | 3.418M |
| Free Cash Flow to Firm (Quarterly) | 8.448M |
| Free Cash Flow Yield | -98.01% |